Date: 2013-09-05
Type of information: Collaboration agreement
Compound:
Company: Go To Market Consulting (USA) Debiopharm (Switzerland)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On September 5, 2013, Go To Market Consulting, a San Francisco headquartered business development representation and marketing services life sciences consulting firm, and Debiopharm, the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs, have entered into an alliance to identify and scout West Coast companies, research institutes and/or individual investigators with in-licensing opportunities, including new compounds, products and/or technologies in oncology, auto-immune, infectious disease and metabolic conditions. Go To Market will collaborate with Debiopharm’s existing in-house scouting team for first in-class opportunities for small molecule, antibody and peptide based product candidates.
In recognition of the depth and breadth of life science innovation in the West and in particular, the San Francisco Bay area, known for its culture of innovation, Debiopharm has selected Go To Market to strengthen its local activity in the region. Go To Market will work with Debiopharm’s scouting team to further increase the company’s accessibility to in-licensing opportunities.
Financial terms:
Latest news:
